United Therapeutics (UTHR) Approves New $100M Buyback Plan
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Up)Join SI Premium – FREE
United Therapeutics Corporation (Nasdaq: UTHR) has authorized the repurchase of up to an additional $100 million of the company's common stock. This program will become effective on July 31, 2012, and will remain open for up to one year. Purchases may be made in the open market or in privately negotiated transactions from time to time as determined by United Therapeutics' management and in accordance with the requirements of the U.S. Securities and Exchange Commission.
The company also announced that it had recently completed its previously-announced $300 million repurchase program by purchasing 2,045,192 shares of common stock for $88 million during the second quarter of 2012.
The company also announced that it had recently completed its previously-announced $300 million repurchase program by purchasing 2,045,192 shares of common stock for $88 million during the second quarter of 2012.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fisker (FSR) files form 10-K, sees more job cuts, reiterates going concern doubts
- Cleveland-Cliffs (CLF) Reports Q1, Announces $1.5B Share Buyback
- Ancora Sends Important Letter to Fellow Shareholders on Norfolk Southern (NSC) Turnaround Plan
Create E-mail Alert Related Categories
Stock BuybacksSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
